|1.||Kimura, Akinori: 3 articles (12/2007 - 12/2004)|
|2.||Arimura, Takuro: 3 articles (12/2007 - 12/2004)|
|3.||Lovejoy, David A: 2 articles (01/2013 - 10/2007)|
|4.||Barsyte-Lovejoy, Dalia: 2 articles (01/2013 - 10/2007)|
|5.||Lin, Zhe: 2 articles (09/2010 - 10/2009)|
|6.||Yang, Ming: 2 articles (09/2010 - 10/2009)|
|7.||Li, Liao-Yuan: 2 articles (09/2010 - 10/2009)|
|8.||Gao, Xin: 2 articles (09/2010 - 10/2009)|
|9.||Hori, Hisae: 2 articles (12/2007 - 12/2004)|
|10.||Yasunami, Michio: 2 articles (01/2005 - 12/2004)|
|1.||Prostatic Neoplasms (Prostate Cancer)
08/01/2002 - "A series of 590 consecutive patients who underwent TCAP as primary therapy with curative intent for localized or locally advanced prostate cancer from March 1993 to September 2001 were identified. "
10/01/2007 - "Salvage TCAP is a safe and effective treatment for localized prostate cancer recurrence after radiotherapy."
11/02/2010 - "To evaluate the clinical efficacy, safety and application value of rectal ultrasound-guided targeted cryoablation of prostate (TCAP) in the treatment of T3N0M0 prostate cancer. "
07/01/2008 - "To evaluate erectile function (EF) and voiding function following primary targeted cryoablation of the prostate (TCAP) for clinically localized prostate cancer (CaP) in a contemporary cohort. "
10/01/2007 - "Between May 2000 and November 2005, 100 patients had salvage TCAP for recurrent prostate cancer after radiotherapy; the mean follow-up was 33.5 months. "
|2.||Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/01/2013 - "The genetics of dilated cardiomyopathy: a prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLN."
05/01/2008 - "Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy."
12/07/2004 - "Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy."
01/01/2008 - "Evaluation of the titin-cap gene (TCAP) as candidate for dilated cardiomyopathy in Irish wolfhounds."
01/01/2005 - "A hypertrophic cardiomyopathy-associated titin/connectin mutation (Arg740Leu) was found to increase the binding to actinin, while other dilated cardiomyopathy-associated titin/connectin mutations (Ala743Val and Val54Met) decreased the binding to actinin and Tcap/telethonin, respectively. "
|3.||Wounds and Injuries (Trauma)
|4.||Muscular Dystrophies (Muscular Dystrophy)
11/01/2011 - "A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients."
11/01/2011 - "We screened a large cohort of muscular dystrophy patients for abnormalities in FHL1 (n=102) and TCAP (n=100) and selected patients whose clinical features overlapped the phenotypes previously described for BAG3 (n=9), MATR3 (n=15) and PTRF (n=7). "
11/01/2011 - "TCAP is a rare reported cause of muscular dystrophy not routinely screened in most centres. "
11/01/2009 - "However, the observations that Tcap integrates into the sarcomere at a stage after the Z-disc becomes periodic, and that the sarcomere remains intact in tcap morphants, suggest that defective sarcomere assembly does not contribute to this particular type of muscular dystrophy. "
11/01/2009 - "We show that tcap is functionally conserved, as the Tcap protein appears in the sarcomeric Z-disc and reduction of Tcap resulted in muscular dystrophy-like phenotypes including deformed muscle structure and impaired swimming ability. "
|5.||Breast Neoplasms (Breast Cancer)
12/18/2006 - "We used a genetic association study design to determine if common genetic variation (frequency>or=5%) in a 400-kb region surrounding ERBB2 and containing the PPARBP, CRK7, NEUROD2, PPP1R1B, STARD3, TCAP, PNMT, CAB2, ERBB2, C17ORF37, GRB7 and ZNFN1A3 genes, was associated with breast cancer risk. "
|3.||RNA (Ribonucleic Acid)
|4.||Proteins (Proteins, Gene)